Skip to main content Skip to main navigation menu Skip to site footer

Inflammatory markers for predicting severity, mortality, and need for intensive care treatments of a patient infected with covid-19: a scoping review

  • Satriya Pranata ,
  • Aric Vranada ,
  • Yunie Armiyati ,
  • Amin Samiasih ,
  • Siti Aisah ,
  • Anna Kurnia ,
  • Priyo Sasmito ,
  • Yanuan Ben Olina ,
  • Antonius Rino Chapo ,


Abstract

Introduction: Numerous types of inflammatory markers are used by health workers to predict the patients infected with COVID-19 condition. However, fewer studies have identified the specific inflammatory markers to predict the severity, mortality, and need for intensive care treatments among patients infected with COVID-19. Thus, this scoping review aimed to evaluate and grouping the inflammatory markers related to severity, mortality, and need for intensive care treatments.

Methods: Electronic databases were discovered for studies by elaborating specific proposed keywords related to types of inflammatory markers for predicting the severity, mortality, and need for intensive care treatments of patients infected with COVID-19. Authors independently comprised the literature search, evidence evaluation, and article extraction until the types of inflammatory markers for predicting the severity, mortality, and need for intensive care treatments of patients infected with COVID-19 are discovered.

Results: 8 of 133 identified articles were included. These articles summarized that the mean of thrombocyte volume-to-platelet count ratio (MPV/PLT), the C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI) and lymphocyte to C-reactive protein ratio (LCRP) were significant in predicting mortality. Lymphocyte-to-monocyte ratio (LMR) and Lymphocyte-to-CRP ratio (LCR) were inversely correlated with disease severity. The systemic-immune-inflammation index (SII) and platelet-to-lymphocyte ratio (PLR) findings were statistically significant in predicting disease severity and the need for intensive care treatments. Moreover, Elevated C-reactive protein (CRP), lymphocyte-to-CRP ratio (LCR), and neutrophil-to-lymphocyte ratio (NLR) were statistically significant in predicting the disease severity, need for intensive care treatment, and mortality.

Conclusion: Each of the inflammatory markers has specificity in predicting the severity, mortality, and need for intensive care treatments among patients infected with COVID-19. These predictors can be used by health professionals, particularly nurses in providing the best clinical decisions and nursing care to COVID-19 patients.

Keywords: COVID -19 inflammatory markers mortality intensive care treatment

References

  1. By E, Mccann G, Colleran C. COVID-19 IN THE GLOBAL SOUTH - Impacts and Responses. 2021;
  2. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol [Internet]. acarAvailable from: http://dx.doi.org/10.1038/s41579-020-00459-7 PMID: 33024307
  3. Atmaja HK, Pranata S, Augustin K, Luthfia E. Accessibility of e-EWSS versus Manual EWSS for Detecting the Emergency Condition among Patients with Coronavirus Disease 2019: A Survey Research on Register Nurse in Indonesia. Open Access Maced J Med Sci. 2022;10(G):286–289.
  4. IFRC,OCHA W. COVID-19: Community Insights from the Asia Pacific Region - Indonesia, Malaysia, Myanmar, and Pakistan. 2020; Available from: https://reliefweb.int/report/indonesia/covid-19-community-insights-asia-pacific-region-indonesia-malaysia-myanmar-and
  5. Mulianda D, Rahmanti A, Margiyati M, Sari NW, Haksara E, Pranata S. Behavioral Activation, Mindfulness Exercises, and Loving-Kindness Meditation Exercises as Effective Therapies to Reduce Stress among Nursing Students’ during COVID-19 Pandemic. Open Access Maced J Med Sci. 2022;10(G):228–232.
  6. Kementrian Kesehatan. Dashboard Kasus COVID-19 di Indonesia [Internet]. 2022. Available from: https://www.kemkes.go.id/article/view/20012900002/Kesiapsiagaan-menghadapi-Infeksi-Novel-Coronavirus.html
  7. Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: A review. J Infect Public Health [Internet]. King Saud Bin Abdulaziz University for Health Sciences; 2020;13(11):1619–1629. Available from: https://doi.org/10.1016/j.jiph.2020.07.001 PMID: 32718895
  8. Pranata S, Wu SFV, Purwadi H, Gede D, Putra S, Wulandari H. Exploring of Self-management Experience among Health Professional Survivors from Coronavirus Disease 2019 in West Nusa Tenggara , Indonesia. 2021;9:19–27.
  9. Fathi F, Sami R, Mozafarpoor S, Hafezi H, Motedayyen H, Arefnezhad R, Eskandari N. Immune system changes during COVID-19 recovery play key role in determining disease severity. Int J Immunopathol Pharmacol. 2020;34. PMID: 33076729
  10. Waris A, Din M, Khalid A, Abbas Lail R, Shaheen A, Khan N, Nawaz M, Baset A, Ahmad I, Ali M. Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan’s experience. J Clin Lab Anal. 2021;35(6):1–10. PMID: 34028884
  11. Singh Y, Singh A, Rudravaram S, Soni KD, Aggarwal R, Patel N, Wig N, Trikha A. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as markers for predicting the severity in covid-19 patients: A prospective observational study. Indian J Crit Care Med. 2021;25(8):847–853.
  12. BG S, Gosavi S, Ananda Rao A, Shastry S, Raj SC, Sharma A, Suresh A, Noubade R. Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios: Prognostic Significance in COVID-19. Cureus. 2021;13(1):1–9.
  13. turan demet. The relationship between SII, PLR, LCR, MPV / PLT indexes and prognosis in COVID-19. South Clin Istanbul Eurasia. 2021;32(2):109–115.
  14. Açıksarı G, Koçak M, Çağ Y, Altunal LN, Atıcı A, Çelik FB, Bölen F, Açıksarı K, Çalışkan M. Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study. Biomark Insights. 2021;16.
  15. Acar E, Demir A, Yıldırım B, Kaya MG, Gökçek K. The role of hemogram parameters and C-reactive protein in predicting mortality in COVID-19 infection. Int J Clin Pract. 2021;75(7):1–11. PMID: 33887100
  16. Asghar MS, Khan NA, Haider Kazmi SJ, Ahmed A, Hassan M, Jawed R, Akram M, Rasheed U, Memon GM, Ahmed MU, Tahniyat U, Tirmizi SB. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Community Hosp Intern Med Perspect. 2020;10(6):514–520.
  17. Westphaln KK, Regoeczi W, Masotya M, Vazquez-Westphaln B, Lounsbury K, McDavid L, Lee H, Johnson J, Ronis SD. From Arksey and O’Malley and Beyond: Customizations to enhance a team-based, mixed approach to scoping review methodology. MethodsX [Internet]. 2021;8:101375. Available from: https://www.sciencedirect.com/science/article/pii/S2215016121001680
  18. Arksey H, O’Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32.
  19. Carpio-Orantes L Del, García-Méndez S, Hernández-Hernández SN. Índices neutrófilo/linfocito, plaqueta/linfocito e inmunidad/inflamación sistémica en pacientes con neumonía por COVID-19. Gac Med Mex. 2020;156(6):527–531. PMID: 33877106
  20. Pranata S, Rizka HD, Anna K, Herlinda W, Dwi S, Difran. NB. Public Perceptions of the COVID-19 Pandemic in Indonesia: A Phenomenological Study. Iran J Psychiatry Clin Psychol [Internet]. 2022;28(1):122=137. Available from: https://ijpcp.iums.ac.ir/article-1-3594-en.pdf
  21. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. England; 2020 Dec;588(7836):E6. PMID: 33199918
  22. Wang K, Chen W, Zhou YS, Lian JQ, Zhang Z, Du P, Gong L, Zhang Y, Cui HY, Geng JJ, Wang B, Sun XX, Wang CF, Yang X, Lin P, Deng YQ, Wei D, Yang XM, Zhu YM, Zhang K, Zheng ZH, Miao JL, Guo T, Shi Y, Zhang J, Fu L, Wang QY, Bian H, Zhu P, Chen ZN. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein [Internet]. bioRxiv; 2020. Available from: http://europepmc.org/abstract/PPR/PPR117474
  23. Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020 May;130(5):2202–2205. PMID: 32217834
  24. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, Tan J, Xu Y, Song R, Song M, Wang L, Zhang W, Han B, Yang L, Wang X, Zhou G, Zhang T, Li B, Wang Y, Chen Z, Wang X. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1). PMID: 32434518
  25. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul;180(7):934–943. PMID: 32167524
  26. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. Germany; 2020 Jun;58(7):1021–1028. PMID: 32286245
  27. Bal T, Dogan S, Cabalak M, Dirican E. Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity. Turkish J Biochem. 2020;46(1):21–26.
  28. Okugawa Y, Toiyama Y, Fujikawa H, Ide S, Yamamoto A, Omura Y, Yin C, Kusunoki K, Kusunoki Y, Yasuda H, Yokoe T, Hiro J, Ohi M, Kusunoki M. Prognostic Potential of Lymphocyte-C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy. J Gastrointest Surg Off J Soc Surg Aliment Tract. United States; 2021 Feb;25(2):492–502. PMID: 32040814
  29. Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Journal of medical virology. 2020. p. 1733–1734. PMID: 32242950
  30. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian DS. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2020 Jul;71(15):762–768. PMID: 32161940
  31. Sun S, Cai X, Wang H, He G, Lin Y, Lu B, Chen C, Pan Y, Hu X. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta [Internet]. 2020;507:174–180. Available from: https://www.sciencedirect.com/science/article/pii/S0009898120301790
  32. Liu Y, Liao W, Wan L, Xiang T, Zhang W. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19. Viral Immunol. United States; 2021 Jun;34(5):330–335. PMID: 32297828
  33. Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, Peiris M, Poon LLM, Zhang W. Viral dynamics in mild and severe cases of COVID-19. The Lancet. Infectious diseases. 2020. p. 656–657. PMID: 32199493
  34. Ozder A. A novel indicator predicts 2019 novel coronavirus infection in subjects with diabetes. Diabetes Res Clin Pract. 2020 Aug;166:108294. PMID: 32623037
  35. Nalbant A, Demirci T, Kaya T, Aydın A, Altındiş M, Güçlü E. Can prognostic nutritional index and systemic immune-inflammatory index predict disease severity in COVID-19? Int J Clin Pract [Internet]. 2021/07/14. John Wiley and Sons Inc.; 2021 Oct;75(10):e14544–e14544. Available from: https://pubmed.ncbi.nlm.nih.gov/34137143
  36. Huguet E, Maccallini G, Pardini P, Hidalgo M, Obregon S, Botto F, Koretzky M, Nilsson PM, Ferdinand K, Kotliar C. Reference Values for Neutrophil to Lymphocyte Ratio (NLR), a Biomarker of Cardiovascular Risk, According to Age and Sex in a Latin American Population. Curr Probl Cardiol. United States; 2021 Mar;46(3):100422. PMID: 31103219
  37. Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, Wang G, Fu W, Xiao J, Ding X, Li T, Xiao X, Li C. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med [Internet]. AME Publishing Company; 2020 May;8(9):593. Available from: https://pubmed.ncbi.nlm.nih.gov/32566620
  38. Fu J, Kong J, Wang W, Wu M, Yao L, Wang Z, Jin J, Wu D, Yu X. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thromb Res [Internet]. 2020/05/06. Elsevier Ltd.; 2020 Aug;192:3–8. Available from: https://pubmed.ncbi.nlm.nih.gov/32407937
  39. Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 Aug;180(8):1081–1089. PMID: 32396163
  40. Chan AS, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020 Jul;12(7):448–453. PMID: 32655740
  41. Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, Schindl M. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2020 Mar;24(3):610–618. PMID: 30923999
  42. Furuncuoğlu Y, Tulgar S, Dogan AN, Cakar S, Tulgar YK, Cakiroglu B. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. Italy; 2016 Apr;20(7):1300–1306. PMID: 27097950

How to Cite

Pranata, S. ., Vranada, A. ., Armiyati, Y. ., Samiasih, A., Aisah, S., Kurnia, A., Sasmito, P., Olina, Y. B., & Antonius Rino Chapo. (2023). Inflammatory markers for predicting severity, mortality, and need for intensive care treatments of a patient infected with covid-19: a scoping review. Bali Medical Journal, 12(1), 324–330. https://doi.org/10.15562/bmj.v12i1.3751
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
6

Total
0

Share